{
    "nct_id": "NCT03541889",
    "official_title": "Multi-institutional Prospective Pilot Research of Imaging and Blood Biomarker EValuation of Engraftment After ALlogeneic Hematopoietic Stem Cell Transplantation",
    "inclusion_criteria": "General\n\n* Ability to undergo 18F FLT imaging without sedation\n* Patients > 4 years of age and less than 80 years of age at highest risk for graft failure: cord blood HSCT, haplo HSCT, or lack of engraftment by day 28.\n* Diagnosed with a condition for which hematopoietic stem cell transplant (HSCT) is standard of care and HSCT is planned (Arm A) or occurred (Arm B)\n* In morphologic remission prior to HSCT\n* Patient or guardian able to give informed consent\n* Investigational therapies within past 28 days or planned on protocol are pre-approved by the PI or Site PI\n* Karnofsky or Lansky performance status > 60%\n\nArm A\n\n* A1 Cord blood recipients: Absence of donor specific antibodies to cord HLA\n* Haplo-identical recipients: ≥ 5/10 and < 7/8 allele mismatch donor\n* A2- myeloablative Haplo-identical transplant is planned\n* A3- reduced intensity Haplo-identical transplant is planned (non-myeloablative is excluded)\n* A1- myeloablative or reduced intensity transplant is planned (non-myeloablative is excluded)\n* Diagnosed with a condition for which hematopoietic stem cell transplant (HSCT) is standard of care and HSCT is planned\n* Total bilirubin < 2.5 mg/dL (unless documented Gilbert's syndrome) and transaminases (ALT and AST) < 5 x the upper limit of normal\n* Creatinine clearance or GFR > 60 ml/min/1.73 m2. (performed pre-HSCT)\n* FEV1 > 80% pre or post-bronchiolator whichever is higher and DLCO Adj > 70% (performed pre-HSCT if age appropriate) and Sa02 > 94% on room air\n* Ejection fraction > 50% (performed pre-HSCT)\n\nArm B\n\n• Non-engraftment recipients of HCT with any donor source (related or unrelated): primary graft failure as defined by ANC not > 500 for 3 consecutive days and at least 20 days after HSCT.\n\nInclusion Criteria - Donors\n\n* 1-2 cords and >.4/6 match to recipient for each (as per current National Marrow Donor guidelines), with a dose >2 x 10e6 CD34 cells/kg for each cord OR > 5/10 and <7/8 allele mismatch related donor\n* Institutional guidelines met for donor suitability\nHealthy volunteers allowed\nMust have minimum age of 4 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* History of psychiatric disorder which may compromise compliance with transplant protocol, or which does not allow for appropriate informed consent\n* Clinically significant systemic illness with manifestations of significant organ dysfunction which, in the judgment of the PI, or Co-I, would render the patient unlikely to tolerate the protocol therapy or complete the study\n* Presence of active malignancy from an organ system other than hematopoietic\n* Pregnant or lactating females\n* Patients who are unable or unwilling to use effective form (s) of contraception during the course of the study\n* Prior history of fluorothymidine allergy or intolerance\n* Decline enrolment on CIBMTR research protocol",
    "miscellaneous_criteria": ""
}